IOLCP NSE filing

IOL Chemicals Announces 39th AGM on September 2, 2026, via Video Conference

The RealCase readLow impact Neutral

IOL Chemicals and Pharmaceuticals Limited will hold its 39th AGM on September 2, 2026, at 11:30 AM IST. The meeting will be conducted via Video Conference (VC)/Other Audio Visual Means (OAVM). The AGM Notice and Annual Report for FY2025-26 will be dispatched electronically.

Why it matters

This is a standard procedural announcement for the Annual General Meeting. It does not involve any new financial disclosures, strategic changes, or operational updates that would have a significant impact on the company's stock performance or business operations.

The market read

The announcement is a routine corporate communication regarding the Annual General Meeting schedule and procedures. It does not contain any new financial performance data or strategic decisions that would significantly impact the company's outlook.

IOL Chemicals and Pharmaceuticals Limited (IOLCP) has announced that its 39th Annual General Meeting (AGM) will be held on Wednesday, September 2, 2026, at 11:30 a.m. IST.

The meeting will be conducted exclusively through Video Conferencing (VC) and Other Audio Visual Means (OAVM), in compliance with regulations from the Ministry of Corporate Affairs and SEBI.

Detailed instructions for joining the AGM and participating via VC/OAVM will be provided in the Notice of AGM. Members can also view a live webcast of the proceedings. The AGM Notice and Integrated Annual Report for the financial year 2025-26 will be sent to members via electronic mode to registered email addresses. Physical copies can be requested. Members are advised to update their KYC details and bank mandates for seamless communication and dividend distribution.

Filing to action

What to do with a filing like this

IOL Chemicals and Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by IOL Chemicals and Pharmaceuticals Limited. Read the original for the full detail.

View original filing